Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms (Q42644926)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

4 November 2017

Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms (English)

1 reference

Europe PubMed Central

4 November 2017

single-nucleotide polymorphism

1 reference

based on heuristic

inferred from title

Heyo Klaus Kroemer

3

object named as

Heyo K Kroemer

1 reference

Europe PubMed Central

4 November 2017

author name string

Henriette E Meyer zu Schwabedissen

1

1 reference

Europe PubMed Central

4 November 2017

Celine Verstuyft

2

1 reference

Europe PubMed Central

4 November 2017

Laurent Becquemont

4

1 reference

Europe PubMed Central

4 November 2017

Richard B Kim

5

1 reference

Europe PubMed Central

4 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

6 January 2010

1 reference

Europe PubMed Central

4 November 2017

American Journal of Physiology - Renal Physiology

1 reference

Europe PubMed Central

4 November 2017

298

1 reference

Europe PubMed Central

4 November 2017

F997-F1005

1 reference

Europe PubMed Central

4 November 2017

4

1 reference

Europe PubMed Central

4 November 2017

Organic anion transporter family: current knowledge.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Characterisation of human tubular cell monolayers as a model of proximal tubular xenobiotic handling

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport function

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Transport of paraquat by human organic cation transporters and multidrug and toxic compound extrusion family

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Interactions of n-tetraalkylammonium compounds and biguanides with a human renal organic cation transporter (hOCT2).

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Mechanisms of renal anionic drug transport

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3).

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Identification of multidrug and toxin extrusion (MATE1 and MATE2-K) variants with complete loss of transport activity.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Metformin transport by renal basolateral organic cation transporter hOCT2.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Estimating the contribution of genes and environment to variation in renal drug clearance

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Impact of genetic polymorphisms of transporters on the pharmacokinetic, pharmacodynamic and toxicological properties of anionic drugs

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Role of glutamate residues in substrate recognition by human MATE1 polyspecific H+/organic cation exporter

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

The inhibition of human multidrug and toxin extrusion 1 is involved in the drug-drug interaction caused by cimetidine.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Functional characterization of multidrug and toxin extrusion protein 1 as a facilitative transporter for fluoroquinolones

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

The MATE proteins as fundamental transporters of metabolic and xenobiotic organic cations

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

A human transporter protein that mediates the final excretion step for toxic organic cations

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

G protein beta 3 gene: structure, promoter, and additional polymorphisms

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Identification and ethnic distribution of major haplotypes in the gene GNB3 encoding the G-protein beta3 subunit

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Transcellular transport of organic cations in double-transfected MDCK cells expressing human organic cation transporters hOCT1/hMATE1 and hOCT2/hMATE1.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Genetic variants of the organic cation transporter 2 influence the disposition of metformin

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Polymorphism in human organic cation transporters and metformin action

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Gene expression and regulation of drug transporters in the intestine and kidney

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Physiological and pharmacokinetic roles of H+/organic cation antiporters (MATE/SLC47A).

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Oppositely directed H+ gradient functions as a driving force of rat H+/organic cation antiporter MATE1

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in mice reduces renal secretion of metformin

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Involvement of human multidrug and toxin extrusion 1 in the drug interaction between cimetidine and metformin in renal epithelial cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Micropuncturing the nephron.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Variability in renal clearance of substrates for renal transporters in chinese subjects

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

MATE1 has an external COOH terminus, consistent with a 13-helix topology

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS study

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Functional characterization of the human organic cation transporter 2 variant p.270Ala>Ser.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2).

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00431.2009

21 January 2018

Identifiers

10.1152/AJPRENAL.00431.2009

1 reference

Europe PubMed Central

4 November 2017

release_cmmbzftvbvaldmkvrp7tjrx5se

1 reference

https://api.fatcat.wiki/v0/release/cmmbzftvbvaldmkvrp7tjrx5se

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42644926&oldid=2112379053"